Tech Company Financing Transactions
Ganymede Bio Funding Round
On 12/20/2022, Ganymede Bio raised $12.8 million in Series A financing from Caffeinated Capital.
Transaction Overview
Company Name
Announced On
12/20/2022
Transaction Type
Venture Equity
Amount
$12,750,000
Round
Series A
Investors
Caffeinated Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support the ongoing development of its cloud-native data platform, cloud IDE, and self-service tooling.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3000 El Camino Real Bldg. 4 200
Palo Alto, CA 94306
USA
Palo Alto, CA 94306
USA
Phone
Website
Email Address
Overview
Ganymede is the only whole-lab automation and data integration platform. Connect any lab instrument with any app or pipeline, all in one simple low-code platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Nathan Clark
Co-Founder
Benson Lee
Browse more venture capital transactions:
Prev: 12/20/2022: Kredito venture capital transaction
Next: 12/20/2022: Nectar venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs